Royal Bank of Canada Boosts Edgewise Therapeutics (NASDAQ:EWTX) Price Target to $32.00

Edgewise Therapeutics ( NASDAQ:EWTX – Free Report) had its price target hoisted by Royal Bank of Canada from $28.00 to $32.00 in a report issued on Monday, Benzinga reports. They currently have an outperform rating on the stock.
Read more...